Evidence map›Paper›PMID 40665246›Full record

ArticleBMC cardiovascular disorders2025

Global and Chinese perspectives on the growing burden of heart failure: trends, gender, and age-related differences (1990-2021) based on GBD 2021 data.

Kai Kang, Qianqian Wang, Yujie Li, Changxing Liu, Haozhen Yu, Ning Li

Abstract readComparative Study
In one paragraph

Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Metabolic-inflammatory burden predicts mortality in heart failure across population and ICU cohorts.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kai KangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Qianqian WangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Yujie LiDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Changxing LiuFirst Clinical Medical School, Heilongjiang University of Chinese Medicine, Harbin, 150040, China.
Haozhen YuInstitute of Analytical Chemistry and Instrument for Life Science, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, PR China.
Ning LiDepartment of Nephrology, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, China. 2766543056@qq.com.

Funding

National Nature Science Foundation of China 82205017Natural Science Basic Research Program of Shaanxi 2023-JC-QN-0888Traditional Chinese medicine science and technology innovation quality improvement and capacity expansion plan project TZKN-CXTD-07
6 · The paper itself

Abstract

backgroundHeart failure (HF) is a growing global health issue, contributing to significant disease burden and increased mortality. The Global Burden of Disease (GBD) study offers comprehensive data on HF trends by age, sex, and region.

objectiveThis study aimed to analyze trends in prevalence and years lived with disability (YLDs) of HF in China and globally from 1990 to 2021 based on GBD 2021 data.

methodsA retrospective analysis using GBD 2021 data was conducted, covering HF burden in 204 countries from 1990 to 2021. Data were analyzed using Joinpoint regression and stratified by age and sex.

resultsGlobal HF prevalence increased from 25.43 million in 1990 to 55.50 million in 2021, with an estimated annual percentage change (EAPC) of 2.50%. YLDs rose from 2.42 million to 5.31 million. In China, the EAPC for HF prevalence was 3.18%, surpassing the global rate. Males exhibited higher HF burden than females, and the disease burden rose sharply in those aged 65 and older.

conclusionBoth global and Chinese HF burdens increased from 1990 to 2021, with China experiencing faster growth. Key public health recommendations include improving early screening, promoting lifestyle interventions, enhancing healthcare access, and integrating new therapies for heart failure.

Indexed as

Global HealthHeart FailureAdultAgedAged, 80 and overAge DistributionAge FactorsChinaFemaleGlobal Burden of DiseaseHumansMaleMiddle AgedPrevalenceRetrospective StudiesRisk FactorsAge-standardized rateEpidemiologyGlobal burden of diseaseHeart failureYears lived with disability

Identifiers

PMID40665246
PMCPMC12265289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.